Bacteriological and clinical studies of sulfamethoxazole-trimethoprim ointment therapy against decubitus infected with methicillin-resistant

Shigeru Fujimura, Kunihito Saito, Akira Watanabe, Michinao Mizugaki

    Research output: Contribution to journalArticle

    1 Citation (Scopus)

    Abstract

    The antibiotic sensitivity and in vitro acquired drug resistance of methicillin-resistant Staphylococcus aureus (MRSA) isolated from infected decubitus of six patients to sulfamethoxazole-trimethoprim (ST), vancomycin (VCM), arbekacin (ABK) and minocycline (MINO) were investigated. ST was as active as VCM, ABK and MINO against the MRSA isolates. The above six strains acquired a moderate degree of drug resistance against ST. The level of drug resistance against ST was almost the same as that against VCM, ABK and MINO. However, no marked resistance occurred to these four agents. We applied an ointment (Elase®) containing 0.024% of ST everyday to six patients who had decubitus infected with MRSA. Open decubitus of six patients healed and closed within 34 days (mean) after initiation of this therapy, and the clinical effects were good in all cases. No drug resistance to ST of the MRSA isolated from six cases occurred during or after therapy. Transient photosensitivity was observed in one patient when a 0.048% ST ointment was used, but disappeard when it was replaced with a 0.024% ST ointment. From these results, we conclude that ST ointment therapy is useful for the treatment of decubitus infected with MRSA.

    Original languageEnglish
    Pages (from-to)610-615
    Number of pages6
    JournalChemotherapy
    Volume42
    Issue number5
    DOIs
    Publication statusPublished - 1994 Jan 1

    Keywords

    • MRSA
    • decubitus
    • sulfamethoxazole-trimethoprim
    • sulfamethoxazole-trimethoprim-ointment

    ASJC Scopus subject areas

    • Pharmacology (medical)
    • Infectious Diseases
    • Pharmacology
    • Drug Discovery
    • Oncology

    Fingerprint Dive into the research topics of 'Bacteriological and clinical studies of sulfamethoxazole-trimethoprim ointment therapy against decubitus infected with methicillin-resistant'. Together they form a unique fingerprint.

  • Cite this